This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Graus-Porta, D.
Right arrow Articles by Hynes, N. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Graus-Porta, D.
Right arrow Articles by Hynes, N. E.

 Previous Article  |  Next Article 

Mol. Cell. Biol., 03 1995, 1182-1191, Vol 15, No. 3
Copyright © 1995, American Society for Microbiology

Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling

D Graus-Porta, RR Beerli and NE Hynes
Friedrich Miescher-Institut, Basel, Switzerland.

ErbB-2 becomes rapidly phosphorylated and activated following treatment of many cell lines with epidermal growth factor (EGF) or Neu differentiation factor (NDF). However, these factors do not directly bind ErbB-2, and its activation is likely to be mediated via transmodulation by other members of the type I/EGF receptor (EGFR)- related family of receptor tyrosine kinases. The precise role of ErbB-2 in the transduction of the signals elicited by EGF and NDF is unclear. We have used a novel approach to study the role of ErbB-2 in signaling through this family of receptors. An ErbB-2-specific single-chain antibody, designed to prevent transit through the endoplasmic reticulum and cell surface localization of ErbB-2, has been expressed in T47D mammary carcinoma cells, which express all four known members of the EGFR family. We show that cell surface expression of ErbB-2 was selectively suppressed in these cells and that the activation of the mitogen-activated protein kinase pathway and p70/p85S6K, induction of c- fos expression, and stimulation of growth by NDF were dramatically impaired. Activation of mitogen-activated protein kinase and p70/p85S6K and induction of c-fos expression by EGF were also significantly reduced. We conclude that in T47D cells, ErbB-2 is a major NDF signal transducer and a potentiator of the EGF signal. Thus, our observations demonstrate that ErbB-2 plays a central role in the type I/EGFR-related family of receptors and that receptor transmodulation represents a crucial step in growth factor signaling.


This article has been cited by other articles:

  • Helms, M. W., Kemming, D., Contag, C. H., Pospisil, H., Bartkowiak, K., Wang, A., Chang, S.-Y., Buerger, H., Brandt, B. H. (2009). TOB1 Is Regulated by EGF-Dependent HER2 and EGFR Signaling, Is Highly Phosphorylated, and Indicates Poor Prognosis in Node-Negative Breast Cancer. Cancer Res. 69: 5049-5056 [Abstract] [Full Text]  
  • Kedrin, D., Wyckoff, J., Boimel, P. J., Coniglio, S. J., Hynes, N. E., Arteaga, C. L., Segall, J. E. (2009). ERBB1 and ERBB2 Have Distinct Functions in Tumor Cell Invasion and Intravasation. Clin. Cancer Res. 15: 3733-3739 [Abstract] [Full Text]  
  • Meira, M., Masson, R., Stagljar, I., Lienhard, S., Maurer, F., Boulay, A., Hynes, N. E. (2009). Memo is a cofilin-interacting protein that influences PLC{gamma}1 and cofilin activities, and is essential for maintaining directionality during ErbB2-induced tumor-cell migration. J. Cell Sci. 122: 787-797 [Abstract] [Full Text]  
  • Ben-Jonathan, N., Chen, S., Dunckley, J. A., LaPensee, C., Kansra, S. (2009). Estrogen Receptor-{alpha} Mediates the Epidermal Growth Factor-Stimulated Prolactin Expression and Release in Lactotrophs. Endocrinology 150: 795-802 [Abstract] [Full Text]  
  • Erjala, K., Sundvall, M., Junttila, T. T., Zhang, N., Savisalo, M., Mali, P., Kulmala, J., Pulkkinen, J., Grenman, R., Elenius, K. (2006). Signaling via ErbB2 and ErbB3 Associates with Resistance and Epidermal Growth Factor Receptor (EGFR) Amplification with Sensitivity to EGFR Inhibitor Gefitinib in Head and Neck Squamous Cell Carcinoma Cells.. Clin. Cancer Res. 12: 4103-4111 [Abstract] [Full Text]  
  • Zhan, L., Xiang, B., Muthuswamy, S. K. (2006). Controlled Activation of ErbB1/ErbB2 Heterodimers Promote Invasion of Three-Dimensional Organized Epithelia in an ErbB1-Dependent Manner: Implications for Progression of ErbB2-Overexpressing Tumors.. Cancer Res. 66: 5201-5208 [Abstract] [Full Text]  
  • Lund, C. V., Popkov, M., Magnenat, L., Barbas, C. F. III (2005). Zinc Finger Transcription Factors Designed for Bispecific Coregulation of ErbB2 and ErbB3 Receptors: Insights into ErbB Receptor Biology. Mol. Cell. Biol. 25: 9082-9091 [Abstract] [Full Text]  
  • Liu, Y., Majumder, S., McCall, W., Sartor, C. I., Mohler, J. L., Gregory, C. W., Earp, H. S., Whang, Y. E. (2005). Inhibition of HER-2/neu Kinase Impairs Androgen Receptor Recruitment to the Androgen Responsive Enhancer. Cancer Res. 65: 3404-3409 [Abstract] [Full Text]  
  • Baselga, J., Arteaga, C. L. (2005). Critical Update and Emerging Trends in Epidermal Growth Factor Receptor Targeting in Cancer. JCO 23: 2445-2459 [Abstract] [Full Text]  
  • Shimizu, M., Deguchi, A., Lim, J. T.E., Moriwaki, H., Kopelovich, L., Weinstein, I. B. (2005). (-)-Epigallocatechin Gallate and Polyphenon E Inhibit Growth and Activation of the Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor-2 Signaling Pathways in Human Colon Cancer Cells. Clin. Cancer Res. 11: 2735-2746 [Abstract] [Full Text]  
  • Hendriks, B. S., Orr, G., Wells, A., Wiley, H. S., Lauffenburger, D. A. (2005). Parsing ERK Activation Reveals Quantitatively Equivalent Contributions from Epidermal Growth Factor Receptor and HER2 in Human Mammary Epithelial Cells. J. Biol. Chem. 280: 6157-6169 [Abstract] [Full Text]  
  • Cardinale, A., Filesi, I., Vetrugno, V., Pocchiari, M., Sy, M.-S., Biocca, S. (2005). Trapping Prion Protein in the Endoplasmic Reticulum Impairs PrPC Maturation and Prevents PrPSc Accumulation. J. Biol. Chem. 280: 685-694 [Abstract] [Full Text]  
  • Xu, K.-P., Riggs, A., Ding, Y., Yu, F.-S. X. (2004). Role of ErbB2 in Corneal Epithelial Wound Healing. IOVS 45: 4277-4283 [Abstract] [Full Text]  
  • Zhao, J., Zhang, L.-H., Jia, L.-T., Zhang, L., Xu, Y.-M., Wang, Z., Yu, C.-J., Peng, W.-D., Wen, W.-H., Wang, C.-J., Chen, S.-Y., Yang, A.-G. (2004). Secreted Antibody/Granzyme B Fusion Protein Stimulates Selective Killing of HER2-overexpressing Tumor Cells. J. Biol. Chem. 279: 21343-21348 [Abstract] [Full Text]  
  • Faisal, A., Kleiner, S., Nagamine, Y. (2004). Non-redundant Role of Shc in Erk Activation by Cytoskeletal Reorganization. J. Biol. Chem. 279: 3202-3211 [Abstract] [Full Text]  
  • Goueli, B. S., Janknecht, R. (2004). Upregulation of the Catalytic Telomerase Subunit by the Transcription Factor ER81 and Oncogenic HER2/Neu, Ras, or Raf. Mol. Cell. Biol. 24: 25-35 [Abstract] [Full Text]  
  • Holbro, T., Beerli, R. R., Maurer, F., Koziczak, M., Barbas, C. F. III, Hynes, N. E. (2003). The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation. Proc. Natl. Acad. Sci. USA 100: 8933-8938 [Abstract] [Full Text]  
  • Arteaga, C. L., Baselga, J. (2003). Clinical Trial Design and End Points for Epidermal Growth Factor Receptor-targeted Therapies: Implications for Drug Development and Practice. Clin. Cancer Res. 9: 1579-1589 [Full Text]  
  • Labriola, L., Salatino, M., Proietti, C. J., Pecci, A., Coso, O. A., Kornblihtt, A. R., Charreau, E. H., Elizalde, P. V. (2003). Heregulin Induces Transcriptional Activation of the Progesterone Receptor by a Mechanism That Requires Functional ErbB-2 and Mitogen-Activated Protein Kinase Activation in Breast Cancer Cells. Mol. Cell. Biol. 23: 1095-1111 [Abstract] [Full Text]  
  • Fleishman, S. J., Schlessinger, J., Ben-Tal, N. (2002). A putative molecular-activation switch in the transmembrane domain of erbB2. Proc. Natl. Acad. Sci. USA 99: 15937-15940 [Abstract] [Full Text]  
  • Yen, L., Benlimame, N., Nie, Z.-R., Xiao, D., Wang, T., Moustafa, A.-E. A., Esumi, H., Milanini, J., Hynes, N. E., Pages, G., Alaoui-Jamali, M. A. (2002). Differential Regulation of Tumor Angiogenesis by Distinct ErbB Homo- and Heterodimers. Mol. Biol. Cell 13: 4029-4044 [Abstract] [Full Text]  
  • Yakes, F. M., Chinratanalab, W., Ritter, C. A., King, W., Seelig, S., Arteaga, C. L. (2002). Herceptin-induced Inhibition of Phosphatidylinositol-3 Kinase and Akt Is Required for Antibody-mediated Effects on p27, Cyclin D1, and Antitumor Action. Cancer Res. 62: 4132-4141 [Abstract] [Full Text]  
  • Filardo, E. J., Quinn, J. A., Frackelton, A. R. Jr., Bland, K. I. (2002). Estrogen Action Via the G Protein-Coupled Receptor, GPR30: Stimulation of Adenylyl Cyclase and cAMP-Mediated Attenuation of the Epidermal Growth Factor Receptor-to-MAPK Signaling Axis. Mol. Endocrinol. 16: 70-84 [Abstract] [Full Text]  
  • Lu, Y., Zi, X., Zhao, Y., Mascarenhas, D., Pollak, M. (2001). Insulin-Like Growth Factor-I Receptor Signaling and Resistance to Trastuzumab (Herceptin). JNCI J Natl Cancer Inst 93: 1852-1857 [Abstract] [Full Text]  
  • Nakae, J., Kido, Y., Accili, D. (2001). Distinct and Overlapping Functions of Insulin and IGF-I Receptors. Endocr. Rev. 22: 818-835 [Abstract] [Full Text]  
  • Moulder, S. L., Yakes, F. M., Muthuswamy, S. K., Bianco, R., Simpson, J. F., Arteaga, C. L. (2001). Epidermal Growth Factor Receptor (HER1) Tyrosine Kinase Inhibitor ZD1839 (Iressa) Inhibits HER2/neu (erbB2)-overexpressing Breast Cancer Cells in Vitro and in Vivo. Cancer Res. 61: 8887-8895 [Abstract] [Full Text]  
  • Hoffmann, I., Eugene, E., Nassif, X., Couraud, P.-O., Bourdoulous, S. (2001). Activation of ErbB2 receptor tyrosine kinase supports invasion of endothelial cells by Neisseria meningitidis. JCB 155: 133-144 [Abstract] [Full Text]  
  • Arteaga, C. L. (2001). The Epidermal Growth Factor Receptor: From Mutant Oncogene in Nonhuman Cancers to Therapeutic Target in Human Neoplasia. JCO 19: 32s-40 [Abstract] [Full Text]  
  • Lenferink, A. E. G., Busse, D., Flanagan, W. M., Yakes, F. M., Arteaga, C. L. (2001). ErbB2/neu Kinase Modulates Cellular p27Kip1 and Cyclin D1 through Multiple Signaling Pathways. Cancer Res. 61: 6583-6591 [Abstract] [Full Text]  
  • Sartor, C. I., Zhou, H., Kozlowska, E., Guttridge, K., Kawata, E., Caskey, L., Harrelson, J., Hynes, N., Ethier, S., Calvo, B., Earp, H. S. III (2001). HER4 Mediates Ligand-Dependent Antiproliferative and Differentiation Responses in Human Breast Cancer Cells. Mol. Cell. Biol. 21: 4265-4275 [Abstract] [Full Text]  
  • Lecerf, J.-M., Shirley, T. L., Zhu, Q., Kazantsev, A., Amersdorfer, P., Housman, D. E., Messer, A., Huston, J. S. (2001). Human single-chain Fv intrabodies counteract in situ huntingtin aggregation in cellular models of Huntington's disease. Proc. Natl. Acad. Sci. USA 98: 4764-4769 [Abstract] [Full Text]  
  • Badache, A., Hynes, N. E. (2001). Interleukin 6 Inhibits Proliferation and, in Cooperation with an Epidermal Growth Factor Receptor Autocrine Loop, Increases Migration of T47D Breast Cancer Cells. Cancer Res. 61: 383-391 [Abstract] [Full Text]  
  • Fiorentino, L., Pertica, C., Fiorini, M., Talora, C., Crescenzi, M., Castellani, L., Alemà, S., Benedetti, P., Segatto, O. (2000). Inhibition of ErbB-2 Mitogenic and Transforming Activity by RALT, a Mitogen-Induced Signal Transducer Which Binds to the ErbB-2 Kinase Domain. Mol. Cell. Biol. 20: 7735-7750 [Abstract] [Full Text]  
  • Wang, Y.-H., Jue, S. F., Maurer, R. A. (2000). Thyrotropin-Releasing Hormone Stimulates Phosphorylation of the Epidermal Growth Factor Receptor in GH3 Pituitary Cells. Mol. Endocrinol. 14: 1328-1337 [Abstract] [Full Text]  
  • Orr, M. S., O'Connor, P. M., Kohn, K. W. (2000). Effects of c-erbB2 Overexpression on the Drug Sensitivities of Normal Human Mammary Epithelial Cells. JNCI J Natl Cancer Inst 92: 987-994 [Abstract] [Full Text]  
  • Lane, H. A., Beuvink, I., Motoyama, A. B., Daly, J. M., Neve, R. M., Hynes, N. E. (2000). ErbB2 Potentiates Breast Tumor Proliferation through Modulation of p27Kip1-Cdk2 Complex Formation: Receptor Overexpression Does Not Determine Growth Dependency. Mol. Cell. Biol. 20: 3210-3223 [Abstract] [Full Text]  
  • Spencer, K. S.R., Graus-Porta, D., Leng, J., Hynes, N. E., Klemke, R. L. (2000). ErbB2 Is Necessary for Induction of Carcinoma Cell Invasion by Erbb Family Receptor Tyrosine Kinases. JCB 148: 385-397 [Abstract] [Full Text]  
  • Kim, S.-O., Houtman, J. C. D., Jiang, J., Ruppert, J. M., Bertics, P. J., Frank, S. J. (1999). Growth Hormone-induced Alteration in ErbB-2 Phosphorylation Status in 3T3-F442A Fibroblasts. J. Biol. Chem. 274: 36015-36024 [Abstract] [Full Text]  
  • Bosilevac, J. M., Olsen, R. J., Bridge, J. A., Hinrichs, S. H. (1999). Tumor Cell Viability in Clear Cell Sarcoma Requires DNA Binding Activity of the EWS/ATF1 Fusion Protein. J. Biol. Chem. 274: 34811-34818 [Abstract] [Full Text]  
  • BRANDT, B. H., ROETGER, A., DITTMAR, T., NIKOLAI, G., SEELING, M., MERSCHJANN, A., NOFER, J.-R., DEHMER-MÖLLER, G., JUNKER, R., ASSMANN, G., ZAENKER, K. S. (1999). c-erbB-2/EGFR as dominant heterodimerization partners determine a motogenic phenotype in human breast cancer cells. FASEB J. 13: 1939-1949 [Abstract] [Full Text]  
  • Muthuswamy, S. K., Gilman, M., Brugge, J. S. (1999). Controlled Dimerization of ErbB Receptors Provides Evidence for Differential Signaling by Homo- and Heterodimers. Mol. Cell. Biol. 19: 6845-6857 [Abstract] [Full Text]  
  • Eagleson, K. L., Levitt, P. (1999). Complex Signaling Responsible for Molecular Regionalization of the Cerebral Cortex. Cereb Cortex 9: 562-568 [Abstract] [Full Text]  
  • Adelsman, M. A., McCarthy, J. B., Shimizu, Y. (1999). Stimulation of beta 1-Integrin Function by Epidermal Growth Factor and Heregulin-beta Has Distinct Requirements for erbB2 but a Similar Dependence on Phosphoinositide 3-OH Kinase. Mol. Biol. Cell 10: 2861-2878 [Abstract] [Full Text]  
  • Olayioye, M. A., Beuvink, I., Horsch, K., Daly, J. M., Hynes, N. E. (1999). ErbB Receptor-induced Activation of Stat Transcription Factors Is Mediated by Src Tyrosine Kinases. J. Biol. Chem. 274: 17209-17218 [Abstract] [Full Text]  
  • Wang, Z., Zhang, L., Yeung, T. K., Chen, X. (1999). Endocytosis Deficiency of Epidermal Growth Factor (EGF) Receptor-ErbB2 Heterodimers in Response to EGF Stimulation. Mol. Biol. Cell 10: 1621-1636 [Abstract] [Full Text]  
  • Pietras, R. J., Poen, J. C., Gallardo, D., Wongvipat, P. N., Lee, H. J., Slamon, D. J. (1999). Monoclonal Antibody to HER-2/neuReceptor Modulates Repair of Radiation-induced DNA Damage and Enhances Radiosensitivity of Human Breast Cancer Cells Overexpressing This Oncogene. Cancer Res. 59: 1347-1355 [Abstract] [Full Text]  
  • Carraway, K. L. III, Rossi, E. A., Komatsu, M., Price-Schiavi, S. A., Huang, D., Guy, P. M., Carvajal, M. E., Fregien, N., Carraway, C. A. C., Carraway, K. L. (1999). An Intramembrane Modulator of the ErbB2 Receptor Tyrosine Kinase That Potentiates Neuregulin Signaling. J. Biol. Chem. 274: 5263-5266 [Abstract] [Full Text]  
  • Sundaresan, S., Roberts, P. E., King, K. L., Sliwkowski, M. X., Mather, J. P. (1998). Biological Response to ErbB Ligands in Nontransformed Cell Lines Correlates with a Specific Pattern of Receptor Expression. Endocrinology 139: 4756-4764 [Abstract] [Full Text]  
  • Pinkas-Kramarski, R., Shelly, M., Guarino, B. C., Wang, L. M., Lyass, L., Alroy, I., Alamandi, M., Kuo, A., Moyer, J. D., Lavi, S., Eisenstein, M., Ratzkin, B. J., Seger, R., Bacus, S. S., Pierce, J. H., Andrews, G. C., Yarden, Y. (1998). ErbB Tyrosine Kinases and the Two Neuregulin Families Constitute a Ligand-Receptor Network. Mol. Cell. Biol. 18: 6090-6101 [Abstract] [Full Text]  
  • Olayioye, M. A., Graus-Porta, D., Beerli, R. R., Rohrer, J., Gay, B., Hynes, N. E. (1998). ErbB-1 and ErbB-2 Acquire Distinct Signaling Properties Dependent upon Their Dimerization Partner. Mol. Cell. Biol. 18: 5042-5051 [Abstract] [Full Text]  
  • Vijapurkar, U., Cheng, K., Koland, J. G. (1998). Mutation of a Shc Binding Site Tyrosine Residue in ErbB3/HER3 Blocks Heregulin-dependent Activation of Mitogen-activated Protein Kinase. J. Biol. Chem. 273: 20996-21002 [Abstract] [Full Text]  
  • Bosilevac, J. M., Gilchrist, C. A., Jankowski, P. E., Paul, S., Rees, A. R., Hinrichs, S. H. (1998). Inhibition of Activating Transcription Factor 1- and cAMP-responsive Element-binding Protein-activated Transcription by an Intracellular Single Chain Fv Fragment. J. Biol. Chem. 273: 16874-16879 [Abstract] [Full Text]  
  • El-Shemerly, M. Y. M., Besser, D., Nagasawa, M., Nagamine, Y. (1997). 12-O-Tetradecanoylphorbol-13acetate Activates the Ras/ Extracellular Signal-regulated Kinase (ERK) Signaling Pathway Upstream of SOS Involving Serine Phosphorylation of Shc in NIH3T3 Cells. J. Biol. Chem. 272: 30599-30602 [Abstract] [Full Text]  
  • Carver, R. S., Mathew, P. M., Russell, W. E. (1997). Hepatic Expression of ErbB3 Is Repressed by Insulin in a Pathway Sensitive to PI-3 Kinase Inhibitors. Endocrinology 138: 5195-5201 [Abstract] [Full Text]  
  • Juhl, H., Downing, S. G., Wellstein, A., Czubayko, F. (1997). HER-2/neu Is Rate-limiting for Ovarian Cancer Growth. CONDITIONAL DEPLETION OF HER-2/neu BY RIBOZYME TARGETING. J. Biol. Chem. 272: 29482-29486 [Abstract] [Full Text]  
  • Arteaga, C. L., Ramsey, T. T., Shawver, L. K., Guyer, C. A. (1997). Unliganded Epidermal Growth Factor Receptor Dimerization Induced by Direct Interaction of Quinazolines with the ATP Binding Site. J. Biol. Chem. 272: 23247-23254 [Abstract] [Full Text]  
  • Zrihan-Licht, S., Lim, J., Keydar, I., Sliwkowski, M. X., Groopman, J. E., Avraham, H. (1997). Association of Csk-homologous Kinase (CHK) (formerly MATK) with HER-2/ErbB-2 in Breast Cancer Cells. J. Biol. Chem. 272: 1856-1863 [Abstract] [Full Text]  
  • Irigoyen, J. P., Besser, D., Nagamine, Y. (1997). Cytoskeleton Reorganization Induces the Urokinase-type Plasminogen Activator Gene via the Ras/Extracellular Signal-regulated Kinase (ERK) Signaling Pathway. J. Biol. Chem. 272: 1904-1909 [Abstract] [Full Text]  
  • Erickson, S., O'Shea, K., Ghaboosi, N, Loverro, L, Frantz, G, Bauer, M, Lu, L., Moore, M. (1997). ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2-and heregulin-deficient mice. Development 124: 4999-5011 [Abstract]  
  • Pinkas-Kramarski, R., Shelly, M., Glathe, S., Ratzkin, B. J., Yarden, Y. (1996). Neu Differentiation Factor/Neuregulin Isoforms Activate Distinct Receptor Combinations. J. Biol. Chem. 271: 19029-19032 [Abstract] [Full Text]  
  • Carver, R. S., Sliwkowski, M. X., Sitaric, S., Russell, W. E. (1996). Insulin Regulates Heregulin Binding and ErbB3 Expression in Rat Hepatocytes. J. Biol. Chem. 271: 13491-13496 [Abstract] [Full Text]  
  • Sasaoka, T., Langlois, W. J., Bai, F., Rose, D. W., Leitner, J. W., Decker, S. J., Saltiel, A. R., Gill, G. N., Kobayashi, M., Draznin, B., Olefsky, J. M. (1996). Involvement of ErbB2 in the Signaling Pathway Leading to Cell Cycle Progression from a Truncated Epidermal Growth Factor Receptor Lacking the C-terminal Autophosphorylation Sites. J. Biol. Chem. 271: 8338-8344 [Abstract] [Full Text]  
  • Chen, X., Levkowitz, G., Tzahar, E., Karunagaran, D., Lavi, S., Ben-Baruch, N., Leitner, O., Ratzkin, B. J., Bacus, S. S., Yarden, Y. (1996). An Immunological Approach Reveals Biological Differences between the Two NDF/Heregulin Receptors, ErbB-3 and ErbB-4. J. Biol. Chem. 271: 7620-7629 [Abstract] [Full Text]  
  • Beerli, R. R., Hynes, N. E. (1996). Epidermal Growth Factor-related Peptides Activate Distinct Subsets of ErbB Receptors and Differ in Their Biological Activities. J. Biol. Chem. 271: 6071-6076 [Abstract] [Full Text]  
  • Bermingham-McDonogh, O, McCabe, K., Reh, T. (1996). Effects of GGF/neuregulins on neuronal survival and neurite outgrowth correlate with erbB2/neu expression in developing rat retina. Development 122: 1427-1438 [Abstract]  
  • Okano, J.-i., Gaslightwala, I., Birnbaum, M. J., Rustgi, A. K., Nakagawa, H. (2000). Akt/Protein Kinase B Isoforms Are Differentially Regulated by Epidermal Growth Factor Stimulation. J. Biol. Chem. 275: 30934-30942 [Abstract] [Full Text]  
  • Beerli, R. R., Dreier, B., Barbas, C. F. III (2000). Positive and negative regulation of endogenous genes by designed transcription factors. Proc. Natl. Acad. Sci. USA 97: 1495-1500 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»